Efficacy and Safety of Oral Propranolol for Facial Flushing and Erythema of Rosacea Compare to Doxycycline, Sulaimaniyah, Iraq


  • Kazhwast Muhammed Karim Shahid Dr Nabaz Center for Skin Disease, Directorate of Health, Sulaimani, Kurdistan Region, Iraq. Author
  • Ali Mozan Dahir Al-Ethawi Shahid Dr Nabaz Center for Skin Disease, Directorate of Health, Sulaimani, Kurdistan Region, Iraq. & Department of Medicine, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq. Author




Rosacea, erythema, flushing, propranolol, doxycycline, interventional study


Background: Rosacea is an inflammatory skin disease characterized by erythema and flushing, where topical medications are challenging to control and treat.


Objectives: To investigate the effect of systemic propranolol/doxycycline in treating facial flushing and erythema in patients with rosacea.


Patients and Methods: This randomized control trial study was conducted on 51 patients with rosacea referred to the Sulaimani Dermatology Teaching Center, Sulaimaniyah, Iraq, from October 2021 to August 2022. Among the studied patients, 31 patients were taking oral propranolol, 28 of them did finish the course, while 20 patients were treated with oral doxycycline, 18 of them finished the treatment. Patients have been seen in 5 sessions (12-week treatments), and in each session, the patient's health status, the recovery process of the disease and vital signs have been checked and recorded.


Results: The mean age of patients age was 46.65±10.38 years. Most patients were females (65.2%), did not take any drugs (78.4%), did not have a history of illness in the family (82.6%), had skin type 2, and had flushing distribution in the forehead, nose, cheek, and chin. The most common symptom in patients was a burning sensation, followed by a burning and tingling sensation. The most common sign in both groups was erythema. Propranolol positively affected clinical erythema assessment, area, telangiectasia, total erythema score, systolic/diastolic blood pressure and heart rate. Thus, in 5 visits, erythema was significantly reduced in the propranolol group compared to the doxycycline group (p≤0.002). So that after the 5 visits the CAT score was shown that erythema was significantly reduced in the propranolol group compared to the doxycycline group (p≤0.001).


Conclusions: Propranolol was more effective than doxycycline in the treatment of rosacea’s flushing and erythema.


Yuan X, Huang X, Wang B, et al. (2019). Relationship between rosacea and dietary factors: A

multicenter retrospective case-control survey. Journal of Dermatology 46(3):219-225.

Okhovat J-P, Armstrong AW. (2014). Updates in Rosacea: Epidemiology, Risk Factors, and DOI: https://doi.org/10.1007/s13671-014-0070-5

Management Strategies. Current Dermatology Reports, 3(1):23-28.

Wilkin J, Dahl M, Detmar M, et al. (2002). Standard classification of rosacea: Report of the

National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. Journal

of the American Academy of Dermatology 46(4):584-587.

Gallo RL, Granstein RD, Kang S, et al. (2018). Standard classification and pathophysiology of

rosacea: The 2017 update by the National Rosacea Society Expert Committee. Journal of the

American Academy of Dermatology, 78(1):148-155.

Tan J, Almeida LM, Bewley A, et al. (2017). Updating the diagnosis, classification and assessment

of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. British Journal

of Dermatology, 176(2):431-438.

Baldwin H. (2012). Diagnosis and treatment of rosacea: state of the art. Journal of Drugs in

Dermatology 11(6):725-730.

Steinhoff M, Schmelz M, Schauber J. (2016). Facial Erythema of Rosacea - Aetiology, Different

Pathophysiologies and Treatment Options. Acta Dermato-Venereologica, 96(5):579-586.

Del Rosso JQ. (2012). Advances in understanding and managing rosacea: part 2: the central role,

evaluation, and medical management of diffuse and persistent facial erythema of rosacea. The Journal

of Clinical and Aesthetic Dermatology, 5(3):26-36.

Hengge UR, Ruzicka T, Schwartz RA, et al. (2006). Adverse effects of topical glucocorticosteroids. DOI: https://doi.org/10.1016/j.jaad.2005.01.010

Journal of the American Academy of Dermatology, 54(1):1-15.

Hsu CC, Lee JY. (2012). Pronounced facial flushing and persistent erythema of rosacea DOI: https://doi.org/10.1016/j.jaad.2012.04.017

effectively treated by carvedilol, a nonselective β-adrenergic blocker. Journal of the American

Academy of Dermatology, 67(3):491-493.

Craige H, Cohen JB. (2005). Symptomatic treatment of idiopathic and rosacea-associated

cutaneous flushing with propranolol. Journal of the American Academy of Dermatology, 53(5):881-

Asai Y, Tan J, Baibergenova A, et al. (2016). Canadian Clinical Practice Guidelines for Rosacea. DOI: https://doi.org/10.1177/1203475416650427

Journal of Cutaneous Medicine and Surgery, 20(5):432-445.

Sachs DL, Varani J, Chubb H, et al. (2019). Atrophic and hypertrophic photoaging: clinical,

histologic, and molecular features of 2 distinct phenotypes of photoaged skin. Journal of the American

Academy of Dermatology, 81(2):480-488.

Logger JGM, Olydam JI, Driessen RJB. (2020). Use of beta-blockers for rosacea-associated facial

erythema and flushing: A systematic review and update on proposed mode of action. Journal of the

American Academy of Dermatology, 83(4):1088-1097.

Park J-M, Mun J-H, Song M, et al. (2015). Propranolol, doxycycline and combination therapy for

the treatment of rosacea. The Journal of Dermatology, 42(1):64-69.

Pietschke K, Schaller M. (2018). Long-term management of distinct facial flushing and persistent

erythema of rosacea by treatment with carvedilol. Journal of Dermatological Treatment, 29(3):310-

Chung BY, Kim HO, Park CW, et al. (2022). Relationships of Serum Homocysteine, Vitamin DOI: https://doi.org/10.1155/2022/5479626

B12, and Folic Acid Levels with Papulopustular Rosacea Severity: A Case-Control Study. BioMed

Research International 2022, (1):1-9.

Suggs AK, Macri A, Richmond H, et al. (2020). Treatment of erythematotelangiectatic rosacea

with pulsed‐dye laser and oxymetazoline 1.0% cream: A retrospective study. Lasers in Surgery and

Medicine, 52(1):38-43.

Lova Navarro M, Sánchez-Pedreño Guillen P, Victoria Martínez AM, et al. (2018).

Papulopustular Rosacea: Response to Treatment with Oral Azithromycin. Actas DermoSifiliográficas, 109(6):529-535. DOI: https://doi.org/10.1016/j.adengl.2018.05.015

Chen H, Lai W, Zheng Y. (2021). Rosacea in acne vulgaris patients: Subtype distribution and

triggers assessment—A cross-sectional study. Journal of Cosmetic Dermatology, 20(6):1889-1896.

Dall'Oglio F, Fusto C, Micali G. (2022). Intrafamilial Transmission of Rosacea Spanning Six

Generations: A Retrospective Observational Study. The Journal of Clinical and Aesthetic

Dermatology, 15(2):35-39.

Rainer BM, Fischer AH, Da Silva DLF, et al. (2015). Rosacea is associated with chronic systemic

diseases in a skin severity–dependent manner: Results of a case-control study. Journal of the

American Academy of Dermatology, 73(4):604-608.

Wienholtz NKF, Christensen CE, Coskun H, et al. (2021). Infusion of Pituitary Adenylate

Cyclase–Activating Polypeptide-38 in Patients with Rosacea Induces Flushing and Facial Edema that

Can Be Attenuated by Sumatriptan. Journal of Investigative Dermatology, 141(7):1687-1698.

Halioua B, Cribier B, Frey M, et al. (2017). Feelings of stigmatization in patients with rosacea. DOI: https://doi.org/10.1111/jdv.13748

Journal of the European Academy of Dermatology and Venereology, 31(1):163-168.

Harper J, Del Rosso JQ, Ferrusi IL. Cross-Sectional Survey of the Burden of Illness of Rosacea

by Erythema Severity. Journal of Drugs in Dermatology 2018;17(2):150-158.

Pekmezci E. (2020). Long duration single pulse intense pulsed light application in DOI: https://doi.org/10.5455/annalsmedres.2019.12.874

erythematotelangiectatic rosacea: An instrumental retrospective study. Annals of Medical Research,


Lee JB, Moon J, Moon KR, et al. (2018). Epidemiological and clinical features of rosacea in

Korea: a multicenter cross‐sectional study. The Journal of Dermatology, 45(5):546-553.

Wada-Irimada M, Yamamoto H, Terui H, et al. Characterization of rosacea patients in Tohoku

area of Japan: Retrospective study of 340 rosacea cases. The Journal of Dermatology 2022;49(5):519- DOI: https://doi.org/10.1111/1346-8138.16317

Trave I, Micalizzi C, Gasparini G, et al. (2021). Dermoscopy of papulopustular rosacea and

comparison of dermoscopic features in patients with or without concomitant Demodex folliculorum.

Clinical and Experimental Dermatology, 46(8):1434-1440.

Ge L, Li Y, Wu Y, et al. (2022). Differential Diagnosis of Rosacea Using Machine Learning and DOI: https://doi.org/10.2147/CCID.S373534

Dermoscopy. Clinical, Cosmetic and Investigational Dermatology, 15:1465.

Stefanou E, Gkentsidi T, Spyridis I, et al. (2022). Dermoscopic spectrum of rosacea. JEADV DOI: https://doi.org/10.1002/jvc2.6

Clinical Practice, 1(1):38-44.

Botnaru D, (2020). editor Phenotypic approach of treatment in rosacea. MedEspera;

Srinivasan A. (2019). Propranolol: A 50-Year Historical Perspective. Annals of Indian Academy DOI: https://doi.org/10.4103/aian.AIAN_201_18

of Neurology, 22(1):21-26.

Wang B, Yuan X, Huang X, et al. (2021). Efficacy and safety of hydroxychloroquine for treatment

of patients with rosacea: A multicenter, randomized, double-blind, double-dummy, pilot study.

Journal of American Academic of Dermatology, 84(2):543-545.



How to Cite

Efficacy and Safety of Oral Propranolol for Facial Flushing and Erythema of Rosacea Compare to Doxycycline, Sulaimaniyah, Iraq. (2023). Journal of Zankoy Sulaimani - Part A, 25(2), 11. https://doi.org/10.17656/jzs.10940

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>